Severe hypoglycaemia under abemaciclib administration in a patient with breast cancer: A case report

The current study reports the case of an 80-year-old woman who experienced severe hypoglycaemia after abemaciclib administration, with a recovery time of ~46 h. Abemaciclib is a cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitor that is used to treat metastatic breast cancer. A side effect of abemac...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Mol Clin Oncol
Hlavní autoři: Horie, Tatsuo, Kijima, Tsunetaka, Yamaguchi, Minekazu, Honda, Satoshi, Horie, Miyako, Ishitobi, Kazunari, Yamagata, Shingo, Sakano, Shigeru, Kurokohchi, Kazutaka
Médium: Artigo
Jazyk:Inglês
Vydáno: D.A. Spandidos 2021
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7849062/
https://ncbi.nlm.nih.gov/pubmed/33604051
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2021.2223
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky